Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1966 8
1967 15
1968 15
1969 11
1970 20
1971 16
1972 9
1973 13
1974 26
1975 33
1976 26
1977 42
1978 31
1979 50
1980 44
1981 38
1982 38
1983 53
1984 63
1985 60
1986 74
1987 91
1988 99
1989 131
1990 165
1991 168
1992 171
1993 184
1994 239
1995 295
1996 251
1997 256
1998 266
1999 336
2000 374
2001 347
2002 305
2003 345
2004 362
2005 372
2006 362
2007 352
2008 355
2009 322
2010 316
2011 316
2012 270
2013 246
2014 260
2015 245
2016 215
2017 173
2018 166
2019 143
2020 163
2021 153
2022 136
2023 95
2024 116
2025 132
2026 88

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,261 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy.
Karjalainen A, Heikkinen J, Savolainen MJ, Bäckström AC, Salinto M, Kesäniemi YA. Karjalainen A, et al. Br J Obstet Gynaecol. 1997 Nov;104 Suppl 16:38-43. doi: 10.1111/j.1471-0528.1997.tb11566.x. Br J Obstet Gynaecol. 1997. PMID: 9389782 Clinical Trial.
OBJECTIVE: To investigate changes in plasma lipid and lipoprotein levels induced by peroral oestrogen replacement and transdermal oestradiol gel therapy. DESIGN: The effects of peroral oestradiol valerate tablets (2 mg) and placebo gel were compared with 1g transder …
OBJECTIVE: To investigate changes in plasma lipid and lipoprotein levels induced by peroral oestrogen replacement and transdermal oestrad …
The effect of acupuncture on postmenopausal symptoms and reproductive hormones: a sham controlled clinical trial.
Sunay D, Ozdiken M, Arslan H, Seven A, Aral Y. Sunay D, et al. Acupunct Med. 2011 Mar;29(1):27-31. doi: 10.1136/aim.2010.003285. Acupunct Med. 2011. PMID: 21383392 Clinical Trial.
Menopausal symptoms were assessed using the Menopause Rating Scale (MRS). The serum oestradiol, follicular stimulating hormone (FSH) and luteinising hormone (LH) levels were measured at baseline and again after the first and last sessions. ...In the acupuncture group LH le …
Menopausal symptoms were assessed using the Menopause Rating Scale (MRS). The serum oestradiol, follicular stimulating hormone (FSH) …
The suppression of puerperal lactation with bromocryptine.
Willmott MP, Colhoun EM, Bolton AE. Willmott MP, et al. Acta Obstet Gynecol Scand. 1977;56(2):145-9. doi: 10.3109/00016347709158357. Acta Obstet Gynecol Scand. 1977. PMID: 324230 Clinical Trial.
The therapeutic value of 2-Br-alpha-ergocryptine for the suppression of puerperal lactation was studied in 30 normal women; 16 received the drug, 14 were controls. In six women plasma levels of FSH, oestradiol and alpha-lactalbulmin were measured in labour and in the early …
The therapeutic value of 2-Br-alpha-ergocryptine for the suppression of puerperal lactation was studied in 30 normal women; 16 received the …
Absorption and bioavailability of oestradiol from a gel, a patch and a tablet.
Järvinen A, Nykänen S, Paasiniemi L. Järvinen A, et al. Maturitas. 1999 Jun 21;32(2):103-13. doi: 10.1016/s0378-5122(99)00021-3. Maturitas. 1999. PMID: 10465378 Clinical Trial.
OBJECTIVES: To compare oestradiol and oestrone concentrations and bioavailability after a single dose and at a steady state during oral oestradiol valerate, transdermal oestradiol gel and transdermal oestradiol patch treatments. ...In the first study, …
OBJECTIVES: To compare oestradiol and oestrone concentrations and bioavailability after a single dose and at a steady state during or …
Improvement in depression with oestrogen treatment in women with schizophrenia.
Lascurain MB, Camuñas-Palacín A, Thomas N, Breadon C, Gavrilidis E, Hudaib AR, Gurvich C, Kulkarni J. Lascurain MB, et al. Arch Womens Ment Health. 2020 Apr;23(2):149-154. doi: 10.1007/s00737-019-00959-3. Epub 2019 Mar 21. Arch Womens Ment Health. 2020. PMID: 30903287 Clinical Trial.
This study investigates the effect of oestradiol treatment on comorbid depressive symptoms in women with schizophrenia. This study is an 8-week, three-arm, double-blind, randomised-controlled trial. ...The stronger 'antidepressant' effect of 200 mcg transdermal oestradi …
This study investigates the effect of oestradiol treatment on comorbid depressive symptoms in women with schizophrenia. This study is …
Oestrogen therapy for postpartum depression: efficacy and adverse effects. A double-blind, randomized, placebo-controlled pilot study.
Kettunen P, Koistinen E, Hintikka J, Perheentupa A. Kettunen P, et al. Nord J Psychiatry. 2022 Jul;76(5):348-357. doi: 10.1080/08039488.2021.1974556. Epub 2021 Sep 17. Nord J Psychiatry. 2022. PMID: 34533410 Clinical Trial.
The aim of this pilot study was to evaluate the efficacy and adverse effects of oestradiol treatment. METHODS: We performed a pilot double-blind, randomized, placebo-controlled study. ...Oestradiol did not disturb breastfeeding. The mean number of other adverse effe …
The aim of this pilot study was to evaluate the efficacy and adverse effects of oestradiol treatment. METHODS: We performed a pilot d …
Effect of aerobic exercise on premenstrual symptoms, haematological and hormonal parameters in young women.
El-Lithy A, El-Mazny A, Sabbour A, El-Deeb A. El-Lithy A, et al. J Obstet Gynaecol. 2015 May;35(4):389-92. doi: 10.3109/01443615.2014.960823. Epub 2014 Oct 3. J Obstet Gynaecol. 2015. PMID: 25279689 Clinical Trial.
There was also a significant decrease in prolactin, oestradiol and progesterone levels. In conclusion, aerobic exercise increases haemoglobin, haematocrit, red cell count and platelet count, and decreases levels of prolactin, oestradiol and progesterone, resulting i …
There was also a significant decrease in prolactin, oestradiol and progesterone levels. In conclusion, aerobic exercise increases hae …
Hormone Therapy Reduces Bone Resorption but not Bone Formation in Postmenopausal Athletes.
Honisett SY, Pagliaro D, Tangalakis K, Kingwell B, Ebeling P, Craven R, Antonopillai J, Apostolopoulos V, Stojanovska L. Honisett SY, et al. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2016 Nov 1;37(2-3):15-21. doi: 10.1515/prilozi-2016-0012. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2016. PMID: 27883324 Free article. Clinical Trial.
METHODS: In a randomised, double blind study, postmenopausal athletes competing at Masters level, received either hormone therapy (50 mug transdermal oestradiol, 5 mg MPA, n = 8) or placebo (n = 7) for 20 weeks. Women were tested before and after treatment for plasma conce …
METHODS: In a randomised, double blind study, postmenopausal athletes competing at Masters level, received either hormone therapy (50 mug tr …
Osteoporosis prevention clinical study program.
Delmas P, Gimona A. Delmas P, et al. Eur J Obstet Gynecol Reprod Biol. 1996 Apr;64 Suppl:S39-45. doi: 10.1016/0301-2115(95)02356-9. Eur J Obstet Gynecol Reprod Biol. 1996. PMID: 8732473 Clinical Trial.
For example, the minimal effective dose regimen of oestradiol needs to be established and the relationship between oestradiol levels and efficacy on bone turnover and bone mass needs to be further clarified. ...In study 201, the treatment regimen is 'cyclic sequenti …
For example, the minimal effective dose regimen of oestradiol needs to be established and the relationship between oestradiol …
Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause.
Takahashi K, Okada M, Ozaki T, Kurioka H, Manabe A, Kanasaki H, Miyazaki K. Takahashi K, et al. Hum Reprod. 2000 May;15(5):1028-36. doi: 10.1093/humrep/15.5.1028. Hum Reprod. 2000. PMID: 10783346 Clinical Trial.
Clinical parameters including Kupperman index (KI) and the degree of satisfaction with symptomatic relief; serum concentrations of oestradiol, FSH and LH; serum lipids; blood pressure; bone mineral density, serum calcium (Ca), alkaline phosphatase (ALP), and urinary Ca wer …
Clinical parameters including Kupperman index (KI) and the degree of satisfaction with symptomatic relief; serum concentrations of oestra …
9,261 results